For the year ending 2025-12-31, XOS had $3,044K increase in cash & cash equivalents over the period. $5,365K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Gross profit | 2,724 |
| Employee related | 18,076 |
| Facility and rent | 3,917 |
| Insurance | 3,183 |
| Depreciation | 1,984 |
| Professional services | 1,625 |
| Computer and software as a service | 2,053 |
| Research and development materials | 1,656 |
| Other | 3,313 |
| Gain on operating lease termination | 9,875 |
| Other expense, net | -2,137 |
| Change in fair value of derivative instruments | 48 |
| Change in fair value of earn-out shares liability | 0 |
| Provision for income taxes | 23 |
| Net loss | -25,320 |
| Depreciation | 2,183 |
| Amortization of right-of-use assets | 1,659 |
| Amortization of debt discounts and issuance costs | 30 |
| Amortization of insurance premiums | 2,430 |
| Inventory reserves | -263 |
| Impairment of property and equipment and assets held-for-sale | 564 |
| Change in fair value of derivative instruments | 48 |
| Change in fair value of earn-out shares liability | 0 |
| Gain on operating lease termination | 9,875 |
| Stock-based compensation expense | 7,407 |
| Bad debt expense | 2 |
| Other non-cash items | -1,068 |
| Accounts receivable | -20,833 |
| Inventories | -10,895 |
| Prepaid expenses and other current assets | 501 |
| Other assets | -907 |
| Accounts payable | -6,458 |
| Other liabilities | -148 |
| Net cash provided by (used in) operating activities | 5,365 |
| Proceeds from the disposal of assets held for sale | 61 |
| Purchases of property and equipment | 0 |
| Net cash acquired in acquisition of electrameccanica vehicles corp | 0 |
| Net cash provided by investing activities | 61 |
| Principal payment for equipment leases | 1,973 |
| Proceeds from short-term insurance financing note | 2,609 |
| Payment for short-term insurance financing note | 2,899 |
| Payments on convertible notes | 1,500 |
| Stock option exercises | 0 |
| Taxes paid related to net share settlement of stock-based awards | 1,021 |
| Proceeds from sale and issuance of common stock | 2,402 |
| Net cash used in financing activities | -2,382 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 3,044 |
| Cash, cash equivalents and restricted cash, beginning of year | 10,996 |
| Cash, cash equivalents and restricted cash, end of year | 14,040 |
| Cash and cash equivalents | 14,040 |
Xos, Inc. (XOS)
Xos, Inc. (XOS)